A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway

Peng Xu, Shanjuan Wang, Dongyue Pang

Open source

DOI
10.1155/2021/8386848
Published
2021-09-28
Container
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2021/8386848,
  title = {A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway},
  author = {Peng Xu and Shanjuan Wang and Dongyue Pang},
  year = {2021},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  doi = {10.1155/2021/8386848},
  url = {https://doi.org/10.1155/2021/8386848}
}

RIS

TY  - JOUR
TI  - A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway
AU  - Peng Xu
AU  - Shanjuan Wang
AU  - Dongyue Pang
PY  - 2021
JO  - Evidence-Based Complementary and Alternative Medicine
DO  - 10.1155/2021/8386848
UR  - https://doi.org/10.1155/2021/8386848
ER  - 

APA

Xu, P., Wang, S., & Pang, D. (2021). A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2021/8386848

Source records